Nomura Asset Management Co. Ltd. Has $59.43 Million Stake in Danaher Co. (NYSE:DHR)

Nomura Asset Management Co. Ltd. cut its stake in Danaher Co. (NYSE:DHR) by 5.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 258,905 shares of the conglomerate’s stock after selling 14,330 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Danaher were worth $59,432,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in DHR. Heck Capital Advisors LLC bought a new position in shares of Danaher during the fourth quarter worth about $27,000. Decker Retirement Planning Inc. bought a new position in shares of Danaher during the 4th quarter worth approximately $31,000. Golden State Wealth Management LLC acquired a new stake in shares of Danaher in the fourth quarter valued at approximately $31,000. Strategic Financial Concepts LLC bought a new stake in shares of Danaher in the fourth quarter worth $31,000. Finally, Pineridge Advisors LLC grew its position in Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 57 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of recent research reports. Barclays reduced their price objective on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. The Goldman Sachs Group upgraded Danaher from a “neutral” rating to a “buy” rating and set a $260.00 price objective on the stock in a research note on Friday, March 21st. Scotiabank started coverage on shares of Danaher in a research note on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price for the company. JPMorgan Chase & Co. dropped their target price on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Finally, Stifel Nicolaus raised Danaher from a “hold” rating to a “buy” rating and set a $260.00 price target on the stock in a research report on Friday, March 14th. Five analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $278.24.

Danaher Stock Performance

NYSE:DHR opened at $205.69 on Friday. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The stock’s 50-day simple moving average is $214.57 and its 200 day simple moving average is $236.90. The firm has a market capitalization of $147.01 billion, a PE ratio of 38.96, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the prior year, the business posted $2.09 EPS. On average, analysts anticipate that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.62%. The ex-dividend date of this dividend is Friday, March 28th. This is a positive change from Danaher’s previous quarterly dividend of $0.27. Danaher’s payout ratio is 24.24%.

Insider Buying and Selling

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 11.10% of the stock is currently owned by insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.